JIVE (LARIMAR)
To evaluate the safety and tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of subcutaneous (SC) administration of CTI-1601 over 28 days in subjects with Friedreich's ataxia (FRDA).
- Investigator
- Sub Subramony
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Vertex
- Investigator
- Sub Subramony
- Status
- Accepting Candidates
Avidity FSHD
A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral…
- Investigator
- Sub Subramony
- Status
- Accepting Candidates
- Ages
- 16 Years - 70 Years
- Sexes
- All